Judi Health (FKA Capital Rx), a NYC-based enterprise health technology company and benefit administrator, raised $400M in funding. The rebranding is concurrent with the investment. The round consisted of a $252M Series F funding round along with additional investments into the company’s securities, scheduled to close in early October, led by Wellington Management and General Catalyst, with participation from Generation Investment Management, Growth Equity at Goldman Sachs Alternatives, 9Yards Capital, B Capital, Edison Partners, Prime Health Investments, and Transformation Capital, among others. The company intends to use the funds to expand its PBM operations and deploy its Enterprise Health Platform (EHP) to bring a full suite of employer-facing health benefits services. Founded in late 2017 by Chief Executive Officer AJ Loiacono and Chief Technology Officer Ryan Kelly, Judi Health is a health technology company providing a comprehensive suite of solutions for employers and health plans, including:Capital Rx: a public benefit corporation delivering full-service pharmacy benefit management (PBM) solutions to self-insured employersJudi Health: full-service health benefit management for employers, TPAs, and health plansJudi: a single, scalable SaaS solution that health plans can utilize to manage all their claim workflowsWith more than 4 million employer PBM members and over 54 million health plan lives already contracted to run on the Judi platform, the company is now entering the broader health benefits market.